LON:NIPT - Premaitha Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 8.60 -0.30 (-3.37 %)
(As of 10/21/2018 04:59 AM ET)
Previous CloseGBX 8.60
Today's RangeGBX 8.50 - GBX 8.80
52-Week RangeGBX 4.05 - GBX 12.50
Volume378,371 shs
Average Volume395,406 shs
Market Capitalization£14.13 million
P/E RatioN/A
Dividend YieldN/A
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

Receive NIPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NIPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Medical Laboratories & Research


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-181.07%
Return on Equity-248.27%
Return on Assets-56.62%


Outstanding Shares321,220,000
Market Cap£14.13 million

Premaitha Health (LON:NIPT) Frequently Asked Questions

What is Premaitha Health's stock symbol?

Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."

How were Premaitha Health's earnings last quarter?

Premaitha Health PLC (LON:NIPT) announced its earnings results on Friday, December, 29th. The company reported ($2.00) EPS for the quarter. The business had revenue of $2.71 million for the quarter. Premaitha Health had a negative return on equity of 248.27% and a negative net margin of 181.07%. View Premaitha Health's Earnings History.

Who are some of Premaitha Health's key competitors?

Some companies that are related to Premaitha Health include DiaSorin (DIA), Polarityte (COOL), Spectral Medical (EDT), VolitionRX (VNRX), ANGLE (AGL) and Proteome Sciences (PRM).

Who are Premaitha Health's key executives?

Premaitha Health's management team includes the folowing people:
  • Dr. Stephen Little, Exec. Vice Chairman (Age 61)
  • Mr. Barry Hextall, CFO & Exec. Director
  • Dr. William Tzocor Denman M.D., MBChB,FRCA, IV, Chief Medical Officer & Exec. Director (Age 55)
  • Mr. Peter Collins, Chief Commercial Officer & Exec. Director (Age 59)
  • Mr. Lyn Fafydd Rees, Chief Exec. Officer (Age 45)

How do I buy shares of Premaitha Health?

Shares of NIPT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Premaitha Health's stock price today?

One share of NIPT stock can currently be purchased for approximately GBX 8.60.

How big of a company is Premaitha Health?

Premaitha Health has a market capitalization of £14.13 million. Premaitha Health employs 52 workers across the globe.

What is Premaitha Health's official website?

The official website for Premaitha Health is http://www.premaitha.com/.

How can I contact Premaitha Health?

Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The company can be reached via phone at +44-161-6676865.

MarketBeat Community Rating for Premaitha Health (LON NIPT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  188 (Vote Outperform)
Underperform Votes:  214 (Vote Underperform)
Total Votes:  402
MarketBeat's community ratings are surveys of what our community members think about Premaitha Health and other stocks. Vote "Outperform" if you believe NIPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NIPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2018 by MarketBeat.com Staff

Featured Article: Do You Need a Fiduciary?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel